Loading organizations...
§ Private Profile · 1460 Broadway, New York, NY 10036, US
Virtual-first HMO offering ACA health insurance plans and AI-assisted telehealth for primary and chronic care in the U.S.
Based in New York with research operations in Tel Aviv, Antidote Health is a virtual-first Health Maintenance Organization and telehealth provider that offers AI-assisted primary care, chronic care, and Affordable Care Act health insurance plans. The company operates a consumer and enterprise digital platform targeting uninsured and underinsured Americans through monthly subscription plans, employer coverage, and one-time virtual doctor visits. Operating with an estimated 78 to 150 employees and a clinical network of approximately 70 to 100 medical doctors, the healthcare enterprise has raised $34 million in total venture funding. This capitalization includes a $22 million Series A financing round backed by notable institutional investors such as iAngels, Group 11, Flint Capital, and professional basketball player Giannis Antetokounmpo. Antidote Health was founded in 2020 by Avihai Sodri, Carine-Belle Feder, David Zlotnick, and Ben Enosh.
Antidote Health has raised $41.0M across 3 funding rounds.
Antidote Health has raised $41.0M in total across 3 funding rounds.
Antidote Health has raised $41.0M in total across 3 funding rounds.
Antidote Health's investors include Flint Capital, Group 11, iAngels, Kli Capital, NFX, Welltech Ventures, Zeev Capital, Lior Ron, Moshe Yanai, Ronald Cohen, Dovi Frances, Giannis Antetokounmpo.
Antidote Health is a virtual-first Health Maintenance Organization (HMO) that provides affordable ACA-compliant health insurance plans and AI-assisted telehealth services, targeting underserved communities across select U.S. states including Arizona, California, Florida, New York, Ohio, and Texas.[1][2][5] It serves individuals and small groups seeking accessible care without insurance barriers, solving high costs and limited access by offering $0 copays for virtual visits, mental health support, medications, and chronic condition management, while operating independently of traditional insurers to keep prices low.[1][2][5] The company has shown growth momentum through expansions like entering on-exchange markets in Ohio and Arizona for 2025, reaching 81% and 78% of those states' ACA populations respectively, and earning a Gold Merit Award in 2024 for integrating virtual care with insurance.[2][5]
Antidote Health was founded by a team with expertise in health, insurance, medicine, and technology, driven by frustration with the traditional healthcare model.[2] Co-founder and CEO Avihai Sodri has led key expansions, such as the recent on-exchange market entry.[5] The idea emerged from developing an AI-assisted telehealth service—offering one-time and subscription options—which laid the foundation for their full HMO insurance plans under the Affordable Care Act (ACA).[2] Early traction built on this virtual-first model, evolving to include small group plans and high-profile backing from investor and ambassador Giannis Antetokounmpo, fueling their mission to make quality care a basic human right.[2]
(Note: Search results distinguish Antidote Health from Antidote Technologies (antidote.me), a separate firm matching patients to clinical trials; this analysis focuses on Antidote Health as the queried technology company.[3][4])
Antidote Health rides the telehealth and virtual-first insurance wave, accelerated by post-pandemic demand for convenient, low-cost care amid rising U.S. healthcare expenses.[2][5] Timing aligns with ACA open enrollment expansions and regulatory shifts favoring digital HMOs, enabling market penetration in high-need states like Ohio and Arizona.[5] Favorable forces include AI-driven personalization, consumer shift from in-person to app-based services, and investor interest from figures like Giannis Antetokounmpo, positioning it to disrupt a $4 trillion industry fragmented by high deductibles and access gaps.[1][2] By influencing ecosystems through affordable models, it pushes competitors toward hybrid virtual-physical care, broadening equity for underserved populations.[1][5]
Antidote Health is poised for accelerated growth via further state expansions and ACA on-exchange scaling, potentially capturing more of the individual market with its $0 benefit edge.[5] Trends like AI telehealth advancements, mental health prioritization, and value-based care will shape its path, amplifying influence as a payvider model leader. Evolving from telehealth roots to a full HMO disruptor, it could redefine accessibility, tying back to its core fight for care as a human right in an increasingly digital health landscape.[1][2]
Antidote Health has raised $41.0M across 3 funding rounds. Most recently, it raised $7.0M Series A in May 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2023 | $7M Series A | — | Flint Capital, Group 11, IAngels, KLI Capital, NFX, Welltech Ventures, Zeev Capital, Lior RON, Moshe Yanai, Ronald Cohen | Announced |
| Mar 1, 2022 | $22M Series A | IAngels, Flint Capital, Dovi Frances | Welltech Ventures, Moshe Yanai, Giannis Antetokounmpo | Announced |
| Aug 1, 2021 | $12M Seed | IAngels, Welltech Ventures, Flint Capital | Moshe Yanai | Announced |